Tag: Trends
Cooley Market Talks – The Technology Outlook: H2 2026 and Beyond
Public capital markets are back in the strategic conversation for technology companies. The change is not limited to better IPO windows. Companies have a broader set of financing choices, investors are showing an appetite for large growth stories, and a credible public market path can give boards more leverage as […]
Navigating M&A in Today’s Exit Market for Funds
Our M&A team hosted a webinar exploring how exit dynamics are evolving in today’s environment for funds. The discussion examined key decision considerations when evaluating potential portfolio company sales and combinations, including potential friction points. The session offers valuable insight into the current M&A landscape for venture-backed companies and is […]
Coordinating HawkEye’s Acquisition, Financings and IPO at Orbit Speed
Escalating geopolitical tensions have driven a significant increase in demand for critical signals intelligence and radio frequency intelligence data and analytics to advance defense, intelligence and national security interests. For HawkEye 360, a spacetech and defensetech innovator, the surge in product and investor demand created a pivotal opportunity to access public […]
Cooley Market Talks – AI and the New Capital Dynamic: IPOs, M&A and What Comes Next
How AI is changing market dynamics With AI transforming capital-raising dynamics and M&A strategies, our clients are navigating a dynamic moment. On April 28, Cooley Partners Jamie Leigh and Dave Peinsipp were joined by Nicole Irvin and Todd Ebe of Goldman Sachs to discuss how rapidly evolving risks and opportunities […]
Yes, Your CEO’s AI Prompts May Be Discoverable (and Can Be Problematic)
Recently, we were all reminded that any type of internal communications – including AI prompts! – are discoverable and can become the “smoking gun” in a lawsuit. In a $250 million M&A earnout dispute, the buyer was found by the Delaware Court of Chancery to have intentionally undermined the earnout […]
The Private Equity Developments That Defined 2025
Your definitive recap Private equity in 2025 was defined by selective momentum, evolving regulatory dynamics and a renewed emphasis on scale and flexibility. Which developments shaped the industry most? Find out in Cooley’s 2025 Private Equity Year in Review, where we examine the market trends, policy developments and structuring considerations […]
2026 Antitrust Outlook: Learnings From the First Year of ‘America First’ Enforcement
Following the transition to the second Trump administration, the Department of Justice (DOJ) and Federal Trade Commission (FTC) pivoted toward a more “business-friendly” posture in many respects, while pursuing other aggressive theories of harm, reminiscent of the Biden-era antitrust enforcers. The strategic shift toward an “America First Antitrust” policy in […]
Comparative Playbook: Navigating Conflicts in Delaware and Nevada
Companies approaching or having recently completed an IPO often face increased scrutiny around transactions involving insiders, investor-appointed directors or controlling stockholders. To help boards and management teams navigate these issues, Cooley’s Liz Dunshee and Courtney Tygesson put together a comparative playbook outlining how Delaware and Nevada law each address conflicted transactions […]
UK Merger Control in 2026 – What to Expect
In 2025, the UK Competition and Markets Authority (CMA) signalled a significant shift in its enforcement and merger review priorities, emphasising its alignment with the UK government’s pro-growth, pro-business agenda. While speeches by CMA executives in previous years had emphasised the need to avoid under-enforcement, including in the context of […]
Cooley’s 2026 Year Ahead for Life Sciences M&A: Competition and Creativity in a Dynamic Environment
This time last year, we wistfully remarked that M&A activity in the life sciences sector had decided to slim down and join the GLP-1 trend. Since then, dealmakers in the space have discovered their appetite again – and then some. Johnson & Johnson (J&J) kicked off 2025 with its $14.6 […]